Indian generic drugmaker Dr Reddy's Laboratories reported third-quarter profit below expectations on Thursday, weighed down by pricing pressure in the competitive North American market, their biggest ...

2025 is set to be a game-changing year for cancer research, with cutting-edge therapies and technologies driving unprecedented progress in oncology.

This was the stock's third consecutive day of gains.

The latest decision makes Sanofi's Sarclisa the first anti-CD38 therapy for transplant-ineligible patients with front-line ...

The Treasury Department had to dole out the highest yield since 2009 to sell billions in inflation-protected securities. This ...

Technology firms were the best performing sector in the market yesterday, rising 2.3% compared with an overall market gain of ...

Israel says it has killed thousands of the armed group’s members and destroyed much of its infrastructure, but since the cease-fire started Hamas has shown it still holds power in the enclave ...

House G.O.P. Floats Medicaid Cuts and More to Finance Trump’s Huge Agenda President Trump wants a massive tax cut and immigration crackdown bill. Republicans must decide what to cut to help pay ...